אייברנס כמוסות 100 מג
pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 100 mg - palbociclib
אייברנס כמוסות 125 מג
pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 125 mg - palbociclib
אייברנס כמוסות 75 מג
pfizer pharmaceuticals israel ltd - palbociclib - קפסולות - palbociclib 75 mg - palbociclib
אייברנס טבליות 100 מג
pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 100 mg - palbociclib
אייברנס טבליות 125 מג
pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 125 mg - palbociclib
אייברנס טבליות 75 מג
pfizer pharmaceuticals israel ltd - palbociclib - טבליות מצופות פילם - palbociclib 75 mg - palbociclib
נורווסק 5 מג טבליות
pfizer pfe pharmaceuticals israel ltd - amlodipine as besylate - טבליה - amlodipine as besylate 5 mg - amlodipine - amlodipine - mild to moderate hypertension. vasospastic angina ( prinzmetal's or variant angina). chronic stable angina.
סוטנט 12.5 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 12.5 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
סוטנט 25 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 25 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
סוטנט 50 מג
pfizer pharmaceuticals israel ltd - sunitinib as malate - קפסולות - sunitinib as malate 50 mg - sunitinib - sunitinib - sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. sutent is indicated for the treatment of advanced renal cell carcinoma.treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.